Vanderbilt Ingram Cancer Center Archives
Sep. 1, 2022—Vanderbilt researchers have received $5 million in funding from a new initiative by the National Cancer Institute that aims to define how gastric and gastroesophageal junction adenocarcinomas form and evolve at the cellular level.
Sep. 1, 2022—Chic Awearness, a fundraiser for ovarian cancer research at Vanderbilt-Ingram Cancer Center (VICC), is an online event this year from now throughout September with an in-store shopping opportunity to close out the month called Chic Week.
Aug. 25, 2022—by Bill Snyder Vanderbilt University Medical Center has opened a state-of-the-art automated biobanking system that can store as many as 10 million biospecimens, including blood and body fluids, tissue, and genetic and protein material, at temperatures down to minus 80 degrees Celsius. The “BioStore” was purchased from its manufacturer, Massachusetts-based Azenta Life Sciences, with the...
Aug. 17, 2022—A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial.
Aug. 11, 2022—Luke and Susan Simons have endowed a new directorship that will support research so that more people can benefit from immunotherapies.
Aug. 4, 2022—A philanthropic gift of a patient care coordinator designated to assist female bladder cancer patients in education, clinical decision-making, surveillance, support and even screening, is the first of its kind at Vanderbilt University Medical Center.